Skip to main content
placeholder image

Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisation

Journal Article


Abstract


  • BACKGROUND: Disturbed bowel habits are very common in palliative care patients, most commonly thought to be due to opioid use. The peripheral opioid-antagonist methylnaltrexone has been subsidised in Australia to ensure that palliative care patients have timely and equitable access to this medication. The aim of this paper is to describe the use of methylnaltrexone in the first year after it was subsidised for palliative care, in particular focusing on the actual use of this medication compared with predicted need.

Publication Date


  • 2013

Publisher


Citation


  • Clark, K., Rowett, D., Robinson, M., & Currow, D. C. (2013). Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisation. BMJ supportive & palliative care, 3(1), 98-102. doi:10.1136/bmjspcare-2012-000284

Scopus Eid


  • 2-s2.0-84930239124

Start Page


  • 98

End Page


  • 102

Volume


  • 3

Issue


  • 1

Place Of Publication


Abstract


  • BACKGROUND: Disturbed bowel habits are very common in palliative care patients, most commonly thought to be due to opioid use. The peripheral opioid-antagonist methylnaltrexone has been subsidised in Australia to ensure that palliative care patients have timely and equitable access to this medication. The aim of this paper is to describe the use of methylnaltrexone in the first year after it was subsidised for palliative care, in particular focusing on the actual use of this medication compared with predicted need.

Publication Date


  • 2013

Publisher


Citation


  • Clark, K., Rowett, D., Robinson, M., & Currow, D. C. (2013). Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisation. BMJ supportive & palliative care, 3(1), 98-102. doi:10.1136/bmjspcare-2012-000284

Scopus Eid


  • 2-s2.0-84930239124

Start Page


  • 98

End Page


  • 102

Volume


  • 3

Issue


  • 1

Place Of Publication